OXFORD COVID VACCINE SAFE FOR OLDER ADULTS: RESULTS

© JUSTIN TALLIS / AFP The vaccine developed by the University of Oxford and AstraZeneca produced fewer side effects in people aged 56 and over than in younger people. A leading Covid-19 vaccine candidate has shown to safely produce a robust immune response in healthy older adults, its British makers said Thursday as it released its phase 2 trial results.The vaccine, developed by the Univ...